Rxivist logo

Unraveling mitotic protein networks by 3D multiplexed epitope drug screening

By Lorenz Maier, Stefan Kallenberger, Katharina Jechow, Marcel Waschow, Roland Eils, Christian Conrad

Posted 10 Dec 2017
bioRxiv DOI: 10.1101/231779 (published DOI: 10.15252/msb.20188238)

Three-dimensional protein localization intricately determines the functional coordination of cellular processes. The complex spatial context of protein landscape has been assessed by multiplexed immunofluorescent staining or mass spectrometry, applied to 2D cell culture with limited physiological relevance or tissue sections. Here, we present 3D SPECS, an automated technology for 3D Spatial characterization of Protein Expression Changes by microscopic Screening. This workflow encompasses iterative antibody staining of proteins, high-content imaging, and machine learning based classification of mitotic states. This is followed by mapping of spatial protein localization into a spherical, cellular coordinate system, the basis used for model-based prediction of spatially resolved affinities of various mitotic proteins. As a proof-of-concept, we mapped twelve epitopes in 3D cultured epithelial breast spheroids and investigated the network effects of mitotic cancer drugs with known limited success in clinical trials. Our approach reveals novel insights into spindle fragility and global chromatin stress, and predicts unknown interactions between proteins in specific mitotic pathways. 3D SPECS's ability to map potential drug targets by multiplexed immunofluorescence in 3D cell cultured models combined with our automized high content assay will inspire future functional protein expression and drug assays.

Download data

  • Downloaded 398 times
  • Download rankings, all-time:
    • Site-wide: 67,127
    • In systems biology: 1,618
  • Year to date:
    • Site-wide: 128,570
  • Since beginning of last month:
    • Site-wide: 126,876

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)